Related Experiment Videos
Effects of captopril on circulating T lymphocyte subsets
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|July 1, 1987
Summary
Captopril treatment for severe hypertension significantly impacts T lymphocyte subsets in peripheral blood. This study observed changes in OKT4+ cells, indicating captopril affects cellular immunity.
Area of Science:
- Immunology
- Pharmacology
- Cardiovascular Medicine
Background:
- Severe essential hypertension requires effective treatment.
- The impact of antihypertensive drugs on the immune system is an area of ongoing research.
- Captopril is a widely used angiotensin-converting enzyme (ACE) inhibitor for hypertension.
Purpose of the Study:
- To investigate the effect of captopril on circulating peripheral blood T lymphocytes and their subsets.
- To determine if captopril alters the numbers of functionally mature T lymphocytes (OKT3+), class II MHC-reactive T lymphocytes (OKT4+), and class I MHC-reactive T lymphocytes (OKT8+).
Main Methods:
- Monitored T lymphocyte subsets (OKT3+, OKT4+, OKT8+) in six patients with severe essential hypertension.
- Utilized monoclonal antibodies and flow cytometry for cell analysis.
- Measurements were taken before and at intervals during 14 months of captopril treatment.
Main Results:
- A significant increase in the absolute numbers of OKT4+ cells was observed at 2 hours post-treatment (p < 0.05).
- A significant decrease in OKT4+ cells was noted at 12 weeks of captopril administration (p < 0.01).
- No significant changes were reported for OKT3+ or OKT8+ cells in the abstract.
Conclusions:
- Captopril administration demonstrably affects T lymphocyte populations in vivo.
- The observed alterations in OKT4+ cells suggest a potential impact of captopril on cellular immunity.
- Further research is warranted to elucidate the clinical significance of these immunomodulatory effects.